Equities

CRISM' Therapeutics Corp

CRISM' Therapeutics Corp

Actions
FinancialsOpen End and Miscellaneous Investment Vehicles
  • Price (GBX)5.69
  • Today's Change0.185 / 3.36%
  • Shares traded62.75k
  • 1 Year change-83.99%
  • Beta0.3657
Data delayed at least 20 minutes, as of Jun 20 2024 10:46 BST.
More ▼
Improved Notifications for Markets Data Alerts
Improved Notifications for Markets Data Alerts
Want push notifications sent directly to your devices for equity price changes and breaking news stories? Let us know here.
 
Existing alertsView our existing alerts
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Key statistics

CRISM' Therapeutics Corp (CRTX:LSE) set a new 52-week low during Wednesday's trading session when it reached 5.00. Over this period, the share price is down -85.79%.
52-week range
Today
5.00Jun 19 202446.40Jun 22 2023
Short selling activity
Low
Med
High
Provided by S&P Global Market Intelligence
Open5.50
High8.00
Low8.00
Bid5.00
Offer6.00
Previous close5.50
Average volume26.98k
Shares outstanding32.68m
Free float32.52m
P/E (TTM)--
Market cap1.80m GBP
EPS (TTM)-0.2163
GBP
Data delayed at least 20 minutes, as of Jun 20 2024 10:46 BST.
More ▼

Board of Directors

1/4

Robert Schafer, Non-Executive Chairman

2/4

Robin Young, Chief Executive Officer

3/4

Thomas Bowens, Non-Executive Director

4/4

Paul Gazzard, Non-Executive Director

Contact

Registered Office:
Kingston Chambers
P.O. Box 173
Road Town
Tortola
British Virgin Islands

Enquiries:
Amur Minerals Corporation
14 Gaidar Street, Office 9
Khabarovsk 680063
Russia
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.
S&P Global Market Intelligence Short Selling Activity © S&P Global Market Intelligence. All rights reserved.
Although S&P Global Market Intelligence has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of S&P Global Market Intelligence on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.